Voltari Corporation (Nasdaq: VLTC) $4.48. Voltari squeezing to new, 52-week high levels following news last week that Carl Icahn took his stake in the company to 52.3 percent. Shares are up markedly from a close at $0.85 on March 30th.
uniQure N.V. (Nasdaq: QURE) $35.50. uniQure N.V. gaining today after it and Bristol-Myers Squibb announced an agreement that provides Bristol-Myers Squibb with exclusive access to uniQure’s gene therapy technology platform for multiple targets in cardiovascular diseases. The collaboration includes uniQure’s proprietary gene therapy program for congestive heart failure that is intended to restore
